feed,title,long_url,short_url
SeekingAlpha,IZEA dips 4.4% even after double-digit Q4 revenue gain,https://seekingalpha.com/news/3677806,
SeekingAlpha,Surface Oncologyâ€™s SRF617 gets FDA orphan drug status,https://seekingalpha.com/news/3677805,
